Thus, chronic stimulation by RELMβ leads to glucose intolerance and hyperlipidemia associated with impaired insulin signaling, and the activations of the three MAPKs are probably related to suppression of insulin signaling [65]. The gene discussed is RETNLB; the disease is hyperlipidemia.